RecruitingNCT05765656
GP and pharmacist support to reduce benzodiazepine use in older adults
About this title
Read the official source — NCT05765656Behavioural studyAges 65+FranceAnxiety
Understand this study
Who could participate?
Listed age limits: from 65 years.
What will I do during this study?
If assigned to the intervention group, you meet your GP and pharmacist, receive educational materials and have three motivational interviews with the pharmacist. The comparison group receives usual GP and pharmacy care.
- Listed locations
- NantesSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 16, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 400
- Sponsor
- Nantes University Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention
- Study phase
- Not clearly listed
- Locations
- France
- Age range
- Over 65 Years
- Official registry ID
- NCT05765656
- Official title
Show the full official title
Evaluation of the Effectiveness of a Joint General Practitioner-Pharmacist Intervention on the Implementation of Benzodiazepine Deprescribing in the Elderly (BESTOPH-MG Trial): Protocol for a Cluster-randomized Controlled Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Nantes
Questions about this study
Who is behind this study?
The study sponsor is Nantes University Hospital, a hospital or academic medical center.
Who can participate?
Listed age limits: from 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
